Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Immunicon Cutting Work Force To Refocus, Reduce Spending

Aug. 30, 2005

By Jennifer Boggs

Isis' ISIS 13650 Becomes First Drug In iCo's Pipeline

Aug. 26, 2005

By Jennifer Boggs

Isis' ISIS 13650 Becomes First Drug In iCo's Pipeline

Aug. 26, 2005

By Jennifer Boggs

Protez Adds $15M In Series B For Drug-Resistant Antibiotics

Aug. 25, 2005

By Jennifer Boggs

Protez Adds $15M In Series B For Drug-Resistant Antibiotics

Aug. 25, 2005

By Jennifer Boggs

Amylin, Alkermes Jump On Long-Acting Byetta Results

Aug. 24, 2005

By Jennifer Boggs

Amylin, Alkermes Jump On Long-Acting Byetta Results

Aug. 24, 2005

By Jennifer Boggs

Panacos Jumps On Phase IIa Results Of HIV Drug PA-457

Aug. 23, 2005

By Jennifer Boggs

Panacos Jumps On Phase IIa Results Of HIV Drug PA-457

Aug. 23, 2005

By Jennifer Boggs

Nutra Pharma Raising $9.6M For ReceptoPharm Subsidiary

Aug. 22, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...